AAAAAA
Results: 1-25/34
Authors:
NOURI AME
CANNELL H
TEZABWALA BU
Citation: Ame. Nouri et al., QUANTIFICATION OF METABOLIC-ACTIVITY IN TUMOR FRAGMENTS, British journal of biomedical science, 55(3), 1998, pp. 208-212
Authors:
NOURI AME
SMITH S
NEWLAND AC
MACEY MG
Citation: Ame. Nouri et al., COMPARATIVE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) ANTIGENS ON CD5(-) B-CELLS IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)() AND CD5(), European journal of cancer, 34(10), 1998, pp. 1618-1622
Authors:
SHARPE R
OOSTERHUIS W
SKAKKEBAEK NE
LOOIJENGA L
EKBOM A
MENG FJ
NOURI AME
VONEYBEN FE
HEIDENREICH A
Citation: R. Sharpe et al., THE PLATELET-DERIVED GROWTH-FACTOR ALPHA-RECEPTOR 1.5 KB TRANSCRIPT -TARGET FOR MOLECULAR-DETECTION OF TESTICULAR GERM-CELL TUMORS OF ADOLESCENTS AND ADULTS - DISCUSSION, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 106(1), 1998, pp. 213-215
Authors:
OLIVER RTD
BREUER J
NOURI AME
CAMPO S
Citation: Rtd. Oliver et al., MALIGNANCY ASSOCIATED PAPILLOMAVIRUSES AND MORPHOLOGY OF HUMAN BLADDER-CANCER, Cancer surveys, 31, 1998, pp. 29-47
Authors:
NOURI AME
OLIVER RTD
NARGUND VH
Citation: Ame. Nouri et al., CLONAL DEVELOPMENT OF BLADDER-CANCER AND ITS RELEVANCE TO THE CLINICAL POTENTIAL OF HLA-ANTIGEN AND TP53 BASED GENE-THERAPY, Cancer surveys, 31, 1998, pp. 109-128
Authors:
NOURI AME
SYMES MO
Citation: Ame. Nouri et Mo. Symes, RELEVANCE OF THE IMMUNE-SYSTEM IN HUMAN UROLOGICAL MALIGNANCIES - PROSPECTIVE FOR FUTURE CLINICAL TREATMENTS, Urology, 51, 1998, pp. 41-49
Authors:
NOURI AME
RUSSELL MV
CANNELL H
PARIS AMI
OLIVER RTD
Citation: Ame. Nouri et al., CONCORDANCE BETWEEN EPITHELIAL TUMOR-CELL METABOLIC-ACTIVITY AND SUSCEPTIBILITY TO CHEMOSENSITIVITY AND RADIOSENSITIVITY, British Journal of Cancer, 78(2), 1998, pp. 145-145
Authors:
NOURI AME
DABARE AANM
OLIVER RTD
Citation: Ame. Nouri et al., INFLUENCE OF TUMOR-CELL PROLIFERATION ON EXPRESSION OF CELLULAR PHOSPHATASES, British Journal of Cancer, 78(2), 1998, pp. 146-146
Authors:
CANNELL H
NOURI AME
Citation: H. Cannell et Ame. Nouri, CONCOMITANT DEFECTIVE IMMUNE-MECHANISMS AND ENHANCED EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) EXPRESSION IN ORAL SQUAMOUS-CELL CARCINOMA (OSCC), British Journal of Cancer, 78, 1998, pp. 136-136
Authors:
DABARE AANPM
NOURI AME
OLIVER RTD
Citation: Aanpm. Dabare et al., DEVELOPMENT OF NEW MONOCLONAL-ANTIBODIES SPECIFIC FOR TESTIS TISSUE, British Journal of Cancer, 78, 1998, pp. 139-139
Authors:
NOURI AME
BREWER J
NARGUND V
FOWLER C
PARIS AMI
OLIVER RTD
Citation: Ame. Nouri et al., PAPILLOMA-VIRUS (HPV) DNA-SEQUENCES AND HLA-ANTIGEN EXPRESSION IN PAPILLARY TCC BLADDER-CANCER, British Journal of Cancer, 78, 1998, pp. 187-187
Authors:
TEZABWALA BU
NOURI AME
CANNELL H
SYMES M
Citation: Bu. Tezabwala et al., LOCAL ANERGY RATHER THAN SYSTEMIC ANTITUMOR IMMUNITY TO EXPLAIN TUMOR-GROWTH IN AN ANIMAL-MODEL OF ORAL SQUAMOUS-CELL CARCINOMA, Oncology Reports, 4(5), 1997, pp. 883-888
Authors:
NOURI AME
OLIVER RTD
Citation: Ame. Nouri et Rtd. Oliver, TETRAPLOID ARREST WITH OVEREXPRESSED NON-MUTATED P53 IN GERM-CELL CANCERS - RELEVANCE TO THEIR CHEMOSENSITIVITY AND POSSIBLE APPLICATION INNON-GERM CELL CANCERS, International journal of oncology, 11(6), 1997, pp. 1367-1371
Authors:
NOURI AME
CANNELL H
ONGUTI M
TEZABWALA BU
OLIVER RTD
Citation: Ame. Nouri et al., THE POSSIBLE RELEVANCE OF THE EXPRESSION OF MHC ANTIGENS AND OF EGF RECEPTOR IN AGGRESSIVE ORAL TUMORS, International journal of oncology, 10(6), 1997, pp. 1217-1222
Authors:
CANNELL H
TEZABWALA BU
NOURI AME
OLIVER RTD
Citation: H. Cannell et al., GENDER INFLUENCES TUMOR-GROWTH IN A MODEL OF HUMAN ORAL SQUAMOUS-CELLCARCINOMA, International journal of oncology, 10(4), 1997, pp. 741-745
Authors:
NOURI AME
BAITHUN S
OLIVER RTD
Citation: Ame. Nouri et al., CONCOMITANT EXPRESSION OF INDUCIBLE IMMUNOREGULATORY MOLECULES IN BLADDER-TUMOR BIOPSIES, Journal of pathology, 181, 1997, pp. 38-38
Authors:
DABARE AANPM
NOURI AME
REYNARD JM
KILLALA S
OLIVER RTD
Citation: Aanpm. Dabare et al., A NEW APPROACH USING TISSUE ALKALINE-PHOSPHATASE ACTIVITY TO IDENTIFYEARLY TESTICULAR CANCER, British Journal of Urology, 79(3), 1997, pp. 455-460
Authors:
NOURI AME
SHARGHI S
SYMES MO
PARIS AMI
OLIVER RTD
Citation: Ame. Nouri et al., CHARACTERISTICS OF HUMAN TUMOR-CELL LINES AFTER INDUCTION OF MULTIDRUG-RESISTANCE, International journal of oncology, 8(6), 1996, pp. 1189-1193
Authors:
NOURI AME
COMPTON SJ
OLIVER RTD
Citation: Ame. Nouri et al., ACCURATE QUANTITATIVE-ANALYSIS OF CELLULAR PROTEINS USING A COMPUTERIZED SCANNING-AIDED DOT-BLOT TECHNIQUE, British journal of biomedical science, 53(3), 1996, pp. 187-192
Authors:
NOURI AME
LOWDELL M
ENTAZAMI Z
TEZABWALA BU
GOODE A
OLIVER RTD
Citation: Ame. Nouri et al., COMPARISON OF IMMUNOLOGICAL CHANGES BETWEEN SUBCUTANEOUS AND INTRAVENOUS ROUTE OF ADMINISTRATION OF IL-2 IN CANCER-PATIENTS, Urologia internationalis, 56(1), 1996, pp. 1-5
Authors:
NOURI AME
HUSSAIN RF
DOSSANTOS AVL
OLIVER RTD
Citation: Ame. Nouri et al., DEFECTIVE EXPRESSION OF ADHESION MOLECULES ON HUMAN BLADDER-TUMOR ANDHUMAN TUMOR-CELL LINES, Urologia internationalis, 56(1), 1996, pp. 6-12
Authors:
NOURI AME
CANNELL H
Citation: Ame. Nouri et H. Cannell, EXPRESSION OF IMMUNOREGULATORY MOLECULES IN HEAD AND NECK-CANCER, Journal of dental research, 75(5), 1996, pp. 1132-1132
COMPARATIVE EXPRESSION OF MHC ANTIGENS ON NORMAL AND THE CORRESPONDING CD5 POSITIVE LEUKEMIC B-CELLS
Authors:
NOURI AME
MACEY MG
SMITH S
OLIVER RTD
NEWLAND AC
Citation: Ame. Nouri et al., COMPARATIVE EXPRESSION OF MHC ANTIGENS ON NORMAL AND THE CORRESPONDING CD5 POSITIVE LEUKEMIC B-CELLS, Immunology, 89, 1996, pp. 84-84
Authors:
NOURI AME
DARAKHSHAN F
CANNELL H
PARIS AMI
OLIVER RTD
Citation: Ame. Nouri et al., THE RELEVANCE OF P53 MUTATION IN UROLOGICAL MALIGNANCIES - POSSIBLE CLINICAL IMPLICATIONS FOR BLADDER-CANCER, British Journal of Urology, 78(3), 1996, pp. 337-344
Authors:
NOURI AME
HUSSAIN RF
OLIVER RTD
Citation: Ame. Nouri et al., EPIDERMAL GROWTH FACTOR-INDUCED PROTECTION OF TUMOR-CELL SUSCEPTIBILITY TO CYTOLYSIS, European journal of cancer, 31A(6), 1995, pp. 963-969